{
  "docId": "019dd923-5ca1-7489-b638-e62bea0762fa",
  "docSlug": "78005f3a3554aa50",
  "documentTitle": "Refueling Innovation Engine Vaccines",
  "authorId": "McKinsey",
  "authorName": "McKinsey",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.333,
  "pageNumber": 27,
  "pageCount": 40,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "matrix_2x2",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a 2x2 matrix to illustrate the shift in innovation difficulty. The top-right quadrant is highlighted with a checkmark to represent past successes.",
  "elementsJson": [
    "headline_text",
    "matrix_2x2",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b638-e62bea0762fa/27",
  "deckHref": "/decks/019dd923-5ca1-7489-b638-e62bea0762fa",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b638-e62bea0762fa.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-e62bea0762fa#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.82,
        "x": 0.09,
        "y": 0.19
      },
      "kind": "framework",
      "text": null,
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1d45117-36c9-4166-84b0-489aa70ac7fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "framework",
      "text": "2x2 Matrix",
      "attrs": null,
      "subkind": null,
      "toolName": "Structuring frame",
      "toolSlug": "structuring-frame",
      "confidence": null,
      "componentId": "019dd951-d3bb-700a-9da7-00c6cdae2b91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.25,
        "x": 0.52,
        "y": 0.022
      },
      "kind": "list",
      "text": "Recent blockbusters: Pneumococcal pneumonia, HPV, Rotavirus, Varicella/Shingles, Dengue",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2fa4e39-ab3d-45b4-9602-661f168fc74a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.03,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "SOURCE: McKinsey",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05641bd9-5565-4f48-8226-ffce417411d9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "The low-hanging fruit no longer exists – needed innovations will be less commercially attractive and less technically feasible than in the past",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5007cada-e0d5-4a2c-9fe4-5082f4c28dad",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "417706f7-9ae2-4d50-8924-89bb352f7521",
      "evidence": "framework: 2x2 Matrix",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "matrix-2x2",
      "slug": null,
      "matchId": "6a75b515-f67e-4806-a395-26ba40db4c3c",
      "evidence": "The slide uses a 2x2 grid to map commercial attractiveness against technical feasibility.",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 27,
      "from": 24,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "aed78475-3aec-4aeb-9912-10ba1bb79adb",
      "evidence": "The deck highlights the increasing costs and economic uncertainty of vaccine development.",
      "position": 0,
      "objective": "What are the costs of inaction in vaccine innovation?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}